Back |
home / stock / meso / meso message board
Subject | By | Source | When |
---|---|---|---|
It will be interesting to see what happens | sokol | investorshub | 08/13/2020 9:32:07 PM |
FDA advisory committee thumbs up on Mesoblast's Ryoncil https://seekingalpha. | biosectinvestor | investorshub | 08/13/2020 9:13:05 PM |
Im hoping they are going to have some | just_waiting | investorshub | 08/13/2020 1:58:31 PM |
WOW | Docstemcell2020 | investorshub | 08/11/2020 6:44:44 PM |
Where are all the posters? | XWAVXALMIMAN | investorshub | 08/11/2020 12:11:24 AM |
A breakout is eminent with US Oncologic Drugs | JPetroInc | investorshub | 07/27/2020 10:53:33 PM |
MESO - ARDS review August 13th looking for | randychub | investorshub | 07/21/2020 2:33:04 PM |
Looks like it's going down to $9 | Docstemcell2020 | investorshub | 06/29/2020 1:57:03 PM |
Mesoblast Shares Surge 206% on Hopes for Its | JPetroInc | investorshub | 06/19/2020 1:47:44 AM |
Mesoblast (ASX:MSB) reveals promising trial results for lung | JPetroInc | investorshub | 06/02/2020 2:07:23 AM |
Mesoblast Reports Strong Financial Position and Substantial Operational | JPetroInc | investorshub | 05/28/2020 1:33:13 AM |
Depends where your froM | randychub | investorshub | 05/13/2020 8:44:58 PM |
Is that a typo? 3.20 cents? | jdlamont | investorshub | 05/13/2020 1:54:39 PM |
News, Short Squeeze, Breakout and More Instantly...
NEW YORK, July 01, 2024 (GLOBE NEWSWIRE) -- Mesoblast Limited (Nasdaq:MESO; ASX:MSB), global leader in allogeneic cellular medicines for inflammatory diseases, today confirmed that it will file its Biologics License Application (BLA) for approval of Ryoncil ® (remestemcel-L) in the treat...
2024-06-27 02:12:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...